ChemoMetec A/S (CHEMM) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.139x

Based on the latest financial reports, ChemoMetec A/S (CHEMM) has a cash flow conversion efficiency ratio of 0.139x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Dkr90.64 Million ≈ $14.18 Million USD) by net assets (Dkr652.59 Million ≈ $102.10 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

ChemoMetec A/S - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how ChemoMetec A/S's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read CHEMM liabilities breakdown for a breakdown of total debt and financial obligations.

ChemoMetec A/S Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of ChemoMetec A/S ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Chutian Dragon Co Ltd
SHE:003040
0.053x
Jiangsu Hanvo Safety Product Co. Ltd.
SHE:300952
0.027x
Cello World Limited
NSE:CELLO
0.010x
HangZhou Radical Energy Saving Technology Co Ltd
SHE:300652
0.065x
Sungho Electronics Corp
KQ:043260
0.063x
GCI Liberty, Inc.
NASDAQ:GLIBK
0.045x
Ulker Biskuvi Sanayi AS
IS:ULKER
0.050x
TOA PAINT (THAILAND)
BK:TOA-R
N/A

Annual Cash Flow Conversion Efficiency for ChemoMetec A/S (2005–2025)

The table below shows the annual cash flow conversion efficiency of ChemoMetec A/S from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see ChemoMetec A/S stock valuation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 Dkr673.36 Million
≈ $105.35 Million
Dkr207.45 Million
≈ $32.46 Million
0.308x +35.01%
2024-06-30 Dkr565.32 Million
≈ $88.45 Million
Dkr129.00 Million
≈ $20.18 Million
0.228x -21.09%
2023-06-30 Dkr533.04 Million
≈ $83.40 Million
Dkr154.15 Million
≈ $24.12 Million
0.289x -41.59%
2022-06-30 Dkr357.20 Million
≈ $55.89 Million
Dkr176.86 Million
≈ $27.67 Million
0.495x +21.59%
2021-06-30 Dkr264.98 Million
≈ $41.46 Million
Dkr107.90 Million
≈ $16.88 Million
0.407x +14.64%
2020-06-30 Dkr202.75 Million
≈ $31.72 Million
Dkr72.02 Million
≈ $11.27 Million
0.355x +5.59%
2019-06-30 Dkr173.34 Million
≈ $27.12 Million
Dkr58.31 Million
≈ $9.12 Million
0.336x -3.44%
2018-06-30 Dkr73.01 Million
≈ $11.42 Million
Dkr25.44 Million
≈ $3.98 Million
0.348x +129.87%
2017-06-30 Dkr64.38 Million
≈ $10.07 Million
Dkr9.76 Million
≈ $1.53 Million
0.152x -49.91%
2016-06-30 Dkr56.85 Million
≈ $8.89 Million
Dkr17.20 Million
≈ $2.69 Million
0.303x +4.70%
2015-06-30 Dkr46.35 Million
≈ $7.25 Million
Dkr13.39 Million
≈ $2.10 Million
0.289x +127.07%
2014-06-30 Dkr44.53 Million
≈ $6.97 Million
Dkr5.67 Million
≈ $886.64K
0.127x -29.63%
2013-06-30 Dkr43.23 Million
≈ $6.76 Million
Dkr7.82 Million
≈ $1.22 Million
0.181x -12.56%
2012-06-30 Dkr42.86 Million
≈ $6.71 Million
Dkr8.87 Million
≈ $1.39 Million
0.207x +39.88%
2011-06-30 Dkr52.71 Million
≈ $8.25 Million
Dkr7.79 Million
≈ $1.22 Million
0.148x +15.98%
2010-06-30 Dkr52.62 Million
≈ $8.23 Million
Dkr6.71 Million
≈ $1.05 Million
0.127x -53.18%
2009-06-30 Dkr56.31 Million
≈ $8.81 Million
Dkr15.33 Million
≈ $2.40 Million
0.272x +950.04%
2008-06-30 Dkr51.71 Million
≈ $8.09 Million
Dkr1.34 Million
≈ $209.81K
0.026x +225.62%
2007-06-30 Dkr39.34 Million
≈ $6.15 Million
Dkr-812.00K
≈ $-127.04K
-0.021x -170.06%
2006-06-30 Dkr16.50 Million
≈ $2.58 Million
Dkr486.00K
≈ $76.04K
0.029x +18.05%
2005-06-30 Dkr-11.34 Million
≈ $-1.77 Million
Dkr-283.00K
≈ $-44.28K
0.025x --

About ChemoMetec A/S

CO:CHEMM Denmark Medical Devices
Market Cap
$925.73 Million
Dkr5.92 Billion DKK
Market Cap Rank
#9501 Global
#45 in Denmark
Share Price
Dkr340.00
Change (1 day)
-0.58%
52-Week Range
Dkr236.80 - Dkr792.00
All Time High
Dkr1128.00
About

ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in the areas of cell and gene therapy, cancer and stem cell research, and development and manufacturing of pharmaceuticals, as well as production and quality control of animal semen, milk, an… Read more